TLR2 and TLR4 expressions in late-onset neonatal sepsis: Is it a potential novel biomarker?

R. Rohsiswatmo, M. Azharry, T. T. Sari, Y. Bahasoan, D. Wulandari

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


BACKGROUND: Late-onset neonatal sepsis (LONS) detection is problematic as no single examinations (blood culture, c-reactive protein (CRP), procalcitonin (PCT)) are reliable. Toll-like receptors (TLRs), which detect the presence of pathogen-associated molecular patterns is a promising novel biomarker, but less studied in LONS. This study aimed to determine neutrophils and monocytes TLR2 and TLR4 expression in LONS and their diagnostic value. METHODS: A cross-sectional study conducted in May and June 2017 involving 52 neonates with clinical late-onset (>72 hours of age) sepsis. We examine complete blood count, I/T ratio, CRP, PCT, as well as TLR2 and TLR4 expression to compared with blood culture as the gold standard. We classified cases into proven or unproven sepsis. RESULT: The incidence of LONS was 32.6% in the subjects. The expression of TLR2 was low in LONS, while TLR4 was high. TLR4 neutrophil expression has 88.2% sensitivity, 20% specificity, 34.9% positive predictive value (PPV), 77.8% negative predictive value (NPV), and an AUC of 0.541. TLR4 monocyte expression has 92.1% sensitivity, 11.4% specificity, 34% PPV, 80% NPV, and an AUC of 0.528. The AUC of CRP is increased from 0.608 to 0.843 after combination with TLR4, comparable with CRP + PCT (AUC 0.829). CONCLUSION: The increase in TLR4 expression has good sensitivity but low specificity. TLR4 expression, in combination with CRP, could become a reliable biomarker for the diagnosis of LONS.

Original languageEnglish
Pages (from-to)361-367
Number of pages7
JournalJournal of Neonatal-Perinatal Medicine
Issue number3
Publication statusPublished - 2021


  • biomarker
  • c-reactive protein
  • Late-onset neonatal sepsis
  • procalcitonin
  • TLR2
  • TLR4


Dive into the research topics of 'TLR2 and TLR4 expressions in late-onset neonatal sepsis: Is it a potential novel biomarker?'. Together they form a unique fingerprint.

Cite this